Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Encoding method and encoding device, decoding method and decoding device and transcoding method and transcoder for multi-object audio signals
Cartridge for conducting a chemical reaction
Apparatus and method for transmitting/receiving data in a communication system
Die seal ring
Computer network running a distributed application
Systems and methods for programming an RFID reader
Electronic system auto-mute control circuit and control method thereof
  Randomly Featured Patents
Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier
Solar element with temperature control device
Ceiling fan
Bracelet connection tool
Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
Method of forming recordable optical element using low absorption materials
Inflatable float
Plasma spraying method
More safe insensitive munition for producing a controlled fragmentation pattern
Methods and devices for analysis of X-ray images